---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-25-000111"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2025-12-05T23:59:59+00:00"
generated_at: "2026-05-16T14:14:58.415073+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics receives Nasdaq extension until June 1, 2026 to meet $1 bid price rule

## Summary
- Received 180-day extension from Nasdaq to June 1, 2026 to regain compliance with $1.00 minimum bid price rule.
- Initial compliance period ended Dec 3, 2025; company previously notified of deficiency on June 6, 2025.
- To regain compliance, closing bid price must be at least $1.00 for ten consecutive business days before June 1, 2026.
- Company considering reverse stock split if needed; trading symbol INTS continues on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001567264-25-000111
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2025-12-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000111/0001567264-25-000111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000111/intensity-20251204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-25-000111
- JSON: https://secwatch.observer/filing/0001567264-25-000111.json
- Plain text: https://secwatch.observer/filing/0001567264-25-000111.txt

## Source-grounded claims
- claim_id: a1e2b93f1fb83db3d209243257d8f4c16ccb9ef9
  claim: INTENSITY THERAPEUTICS, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: December 4, 2025, the “Company received a second letter (the “December 2025 Nasdaq Letter”) from Nasdaq stating that the Company is eligible for an additional 180 calendar days, or until June 1, 2026, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Staff of the Nasdaq (the “Staff”) determined that the Company is eligible for the second 180 calendar day period, or until June 1, 2026, to regain compliance with the Rule based on the Staff’s determination that the Company must continue to meet the continued listing requirement
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000111/0001567264-25-000111-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.